Go to Top

Archive

27-01-2012  Aquamid – a unique long lasting hydrogel

Although they are often considered as identical, currently marketed Polyacrylamide Hydrogels significantly differ…

Read more…

26-02-2011  Contura Signs agreement with Valeo Aesthetics

Contura International is proud to announce Valeo Aesthetics as the exclusive distribution partner for Aquamid® in Canada. Aquamid is a versatile and durable injectable volumizer…

Read more…

19-02-2011  Dr Monheit will be presenting at the South Beach meeting

In a recent survey conducted among US-based dermatologists and plastic surgeons who regularly practice aesthetics in their clinics, more than 85% indicated they would be glad to add Aquamid to their current portfolio. …

Read more…

05-01-2011  Aquamid symposium and scientific session at IMCAS 2011

In January 2011 the aesthetic world’s attention turns to Paris, where Plastic Surgeons from all over the world gather to hear news from the industry and …

Read more…

05-01-2011  US Pivotal Study Proves Aquamid® Safety Profile Similar to Restylane over 12 Months Follow-up

No safety concerns on 24 months extended follow-up – A prospective, randomized, double-masked, multi-center, 2-arm clinical trial, performed at 13 investigational centers…

Read more…

21-10-2010  Contura launches website for HIV patients

Contura launches a new web site with information on using Aquamid® for the correction of facial wasting or facial lipoatrophy….

Read more…

15-10-2010  Contura to open UK office in London

Contura International A/S sets up their UK subsidiary, Contura UK Ltd, in London, England. The new office forms a part of a set of key initiatives to increase Contura’s presence …

Read more…

16-04-2010  Contura Submits Registration Application for Aquamid to the FDA

Contura Submits Registration Application for Aquamid® to the FDA…

Read more…

25-03-2010  Introducing the New Aquamid® Manufactured by Contura International A/S

New State-of-the-Art Facility Certified for the Production of Hydrogel…

Read more…

20-11-2009  Aquamid’s long-term safety and efficacy confirmed in follow-up study with 4800 Orientals

A new study published in Journal of Plastic, Reconstructive and Aesthetic Surgery confirms the long-term safety and efficacy data of Aquamid. In the study …

Read more…

27-10-2009  Positive pivotal Study Results Presented at American Society of Aesthetic Plastic Surgeons (ASPS) Annual Meeting

Results of a pivotal Phase 3 clinical trial for soft volume filler Aquamid®, developed by Contura International A/S, were presented today at the American… …

Read more…

05-10-2009  Aquamid® Safe and Effective in 300-patient U.S. Clinical Trial for the Aesthetic Treatment of Facial Wrinkles

Pivotal Study Results Presented at American Society of Dermatologic Surgery (ASDS) Annual Meeting Results of a pivotal Phase 3 clinical trial for soft volume filler Aquamid®… …

Read more..

16-06-2009  Contura, Leading Permanent Filler Company, Responds to Survey by the British Association of Aesthetic Plastic Surgeons

Information released last week by the British Association of Aesthetic Plastic Surgeons (BAAPS) highlighted their concerns regarding complications due to cosmetic fillers……

Read more…

03-06-2009  New Study Shows High Patient Satisfaction 4 Years after Correcting Facial Lipoatrophy

High patient satisfaction and the long-term safety of Aquamid® was documented in the AIDS Research and Human Retroviruses journal, where the results from a new clinical study……

Read more…

08-07-2008  Positive results for Aquamid® in new lipoatrophy study

A new study of Aquamid® in the management of HIV related lipoatrophy has been published in Plastic and Reconstructive Surgery Journal, Feb. 2008*…

Read more…

06-05-2008  Clinical Data Demonstrates 5-Year Efficacy and Safety of Aquamid® in Facial Augmentation

5-year European Clinical Study shows more than 90% Patient and Physician Satisfaction Contura International A/S today announced that 5-year clinical data…

Read more…

16-08-2007  Aquamid® receives award

The Frost and Sullivan award for Product Differentiation Innovation 2007 goes to Contura for the development and marketing of Aquamid®. The Frost & Sullivan…

Read more…

19-01-2007  48-month efficacy and safety

The 48-month follow-up results of the prospective, multi-centre study of Aquamid® conducted in six European countries have been presented by Dr. Hermann Lampe, Germany…

Read more…

23-10-2006  24-month efficacy and safety results of Aquamid® published

The 24-month follow-up results of the prospective, multi-centre study of Aquamid® conducted in six European countries have been published in Plastic and Reconstructive…

Read more…

23-08-2006  FDA approves start of clinical trials with Aquamid®

FDA approves Contura’s application to initiate clinical trials with Aquamid® in the United States……

Read more…

22-08-2006  Promising 1-year results for urethral bulking

Results of the 1-year clinical study published in BJU International confirms that polyacrylamide hydrogel is a promising new bulking agent for the treatment of… …

Read more…

03-07-2006  Contura obtains ISO certifications

Contura has obtained ISO 13485:2003 and ISO 9001:2000 certificates in June 2006……

Read more…

05-10-2005  New 1-year Aquamid® follow-up article

New 1-year Aquamid® follow-up article by Dr. S. von Bülow et al published in Plastic and Reconstruction Surgery……

Read more…